← Eichor
Condition: Persistent Spinal Pain Syndrome Type 2 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Persistent Spinal Pain Syndrome Type 2

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Differential Target Multiplexed Spinal Cord Stimulation
Phase N/A · 14 location(s) · Moens Maarten · NCT05068011
Neurophysiological Effects of Medication Tapering During Treatment With Spinal Cord Stimulation
Phase N/A · 1 location(s) · Brai²n · NCT07413731
Neuronal Activation Accuracy in Closed-loop Spinal Cord Stimulation
Phase N/A · 1 location(s) · Karel Hanssens · NCT06775535
Pain Medication Tapering for Patients With Persistent Spinal Pain Syndrome Type 2, Treated With Spinal Cord Stimulation.
NA · 3 location(s) · Moens Maarten · NCT05861609
Return to Work for Persistent Spinal Pain Syndrome Type II Patients
NA · 5 location(s) · Moens Maarten · NCT05269212
Neuro-Pain Provides a Dynamic and Interactive Register for the Invasvive Neuromodulatory Therapies for Different Chronic
Phase N/A · 1 location(s) · University Hospital, Antwerp · NCT06835868
Effects of Active Versus Passive Recharge Burst Spinal Cord Stimulation on Pain Experience in Persistent Spinal Pain Syn
NA · 6 location(s) · Rijnstate Hospital · NCT05421273
Evaluation of Medication Tapering on the Sensitivity of the Spinal Cord Using Closed-Loop Spinal Cord Stimulation (Pilot
Phase N/A · 1 location(s) · Brai²n · NCT07502612
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.